Can citalopram (Celexa) and escitalopram (Lexapro) be administered together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, Celexa and Lexapro Should Not Be Given Together

Citalopram (Celexa) and escitalopram (Lexapro) should not be coadministered. This is explicitly contraindicated in the FDA drug labeling because escitalopram is the active S-enantiomer of racemic citalopram—they are essentially the same medication 1.

Why This Combination Is Contraindicated

They Are the Same Drug

  • Escitalopram is literally the therapeutically active component extracted from citalopram
  • Citalopram is a 50:50 mixture of S-citalopram (escitalopram) and R-citalopram
  • Using both simultaneously provides no additional therapeutic benefit—it simply increases the total dose of escitalopram 2, 3

Risk of Serotonin Syndrome

Combining these medications creates an unnecessarily high serotonergic load, increasing the risk of serotonin syndrome, which can be life-threatening. Guidelines explicitly warn that caution should be exercised when combining two or more serotonergic drugs 4. Serotonin syndrome presents with:

  • Mental status changes (confusion, agitation, anxiety)
  • Neuromuscular hyperactivity (tremors, clonus, hyperreflexia, muscle rigidity)
  • Autonomic instability (hypertension, tachycardia, hyperthermia, diaphoresis)
  • Advanced symptoms include fever, seizures, and can progress to death 4, 5, 1

Increased QT Prolongation Risk

Both citalopram and escitalopram prolong the QT interval and carry risk for Torsade de Pointes and sudden cardiac death 6, 7. The FDA has specifically limited maximum doses due to this cardiotoxicity risk. Combining them would:

  • Dramatically increase total drug exposure
  • Amplify QT prolongation effects
  • Particularly dangerous in patients >60 years where maximum doses are already reduced 6, 7
  • Recent data shows 20% of patients >65 years on just 10mg escitalopram alone reach potentially pro-arrhythmic concentrations 8

Clinical Implications

If a Patient Is on One, Don't Add the Other

The appropriate clinical approach when a patient needs medication adjustment:

  • If inadequate response to citalopram: Switch to escitalopram (which is more potent) or switch to a different class of antidepressant entirely
  • If inadequate response to escitalopram: Consider augmentation with a different class of medication (e.g., bupropion, buspirone, or cognitive therapy) 9, 10
  • Never combine citalopram with escitalopram

Limited Evidence for Combining Two SSRIs

Guidelines explicitly state there is limited evidence for using two antidepressants from the same class as either initial treatment or as a treatment endpoint 11. The only acceptable scenario is during a brief cross-titration period when switching from one to another.

Common Pitfalls to Avoid

  1. Prescriber oversight: A new prescriber may not recognize that Lexapro and Celexa are related compounds
  2. Patient self-medication: Patients may have leftover medication from previous prescriptions
  3. Pharmacy dispensing errors: Always verify the patient isn't already on the other medication
  4. Assuming "more is better": Combining these drugs doesn't provide additive benefit, only additive risk

The FDA drug label explicitly states: "Since escitalopram is the active isomer of racemic citalopram (Celexa), the two agents should not be coadministered" 1.

References

Guideline

clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, 2020

Guideline

practice parameter on the use of psychotropic medication in children and adolescents.

Journal of the American Academy of Child and Adolescent Psychiatry, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.